Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
320,175
-
Share change
-
+216,184
-
Total reported value
-
$1,066,183
-
Price per share
-
$3.33
-
Number of holders
-
3
-
Value change
-
+$719,893
-
Number of buys
-
3
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q4 2023
As of 31 Dec 2023,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
320,175 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, BARCLAYS PLC, Kohlberg Kravis Roberts & Co. L.P., MILLENNIUM MANAGEMENT LLC, Pictet Asset Management Holding SA, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
152
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.